Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients
Mauricette Michallet(Université Claude Bernard Lyon 1), Philippe Vanhems(Université Claude Bernard Lyon 1), Samira Kraghel(Hospices Civils de Lyon), Giovanna Cannas(Hôpital Edouard Herriot), Fiorenza Barraco(Hôpital Lyon Sud), Stéphane Picot(Hospices Civils de Lyon), Youcef Chelghoum(Hôpital Edouard Herriot), Mohamed El Hamri(Hospices Civils de Lyon), Marie‐Christine Nicolle(Hôpital Edouard Herriot), Florence Persat(Université Claude Bernard Lyon 1), Xavier Thomas(Hôpital Lyon Sud), Frédérique de Monbrison(Hôpital de la Croix-Rousse), Franck E. Nicolini(Université Claude Bernard Lyon 1), Mohamad Sobh(Ottawa Hospital), Thomas Bénet(Lyon 1 Université), Anne‐Lise Bienvenu(Université Claude Bernard Lyon 1), Hélène Labussière(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud)
European Journal of Clinical Microbiology & Infectious Diseases
September 9, 2011
Cited by 45
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547